Tag: Prostate cancer prevention

According to the Prostate Cancer Prevention Trial, finasteride (5mg) reduced the overall risk of prostate cancer by 25% over seven years. This finding, however, comes with a complex set of trade-offs, prompting many men to question: is finasteride worth it for prostate treatment or prevention?

According to extensive clinical trial data, long-term treatment with finasteride significantly improves the clinical progression of benign prostatic hyperplasia (BPH) in men with enlarged prostates, reducing prostate volume by 20–25% within the first year of treatment. Understanding **what is the success rate of finasteride for prostate** issues is crucial for evaluating its effectiveness in both managing BPH and its role in prostate cancer prevention.